Caris Life Sciences, Inc. (CAI)
28.30
-0.05
(-0.18%)
USD |
NASDAQ |
Oct 02, 16:00
28.44
+0.14
(+0.49%)
After-Hours: 20:00
Caris Life Sciences Enterprise Value : 7.656B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 7.656B |
| October 01, 2026 | 7.671B |
| September 30, 2026 | 8.315B |
| September 29, 2026 | 8.575B |
| September 28, 2026 | 8.631B |
| September 25, 2026 | 8.696B |
| September 24, 2026 | 8.778B |
| September 23, 2026 | 8.603B |
| September 22, 2026 | 8.552B |
| September 21, 2026 | 8.320B |
| September 18, 2026 | 8.131B |
| September 17, 2026 | 8.397B |
| September 16, 2026 | 7.631B |
| September 15, 2026 | 7.713B |
| September 14, 2026 | 7.021B |
| September 11, 2026 | 6.537B |
| September 10, 2026 | 6.453B |
| September 09, 2026 | 6.450B |
| September 08, 2026 | 6.673B |
| September 04, 2026 | 6.744B |
| September 03, 2026 | 6.814B |
| September 02, 2026 | 6.667B |
| September 01, 2026 | 6.662B |
| August 31, 2026 | 6.862B |
| August 28, 2026 | 6.902B |
| Date | Value |
|---|---|
| August 27, 2026 | 7.114B |
| August 26, 2026 | 7.238B |
| August 25, 2026 | 7.574B |
| August 24, 2026 | 7.043B |
| August 21, 2026 | 7.083B |
| August 20, 2026 | 6.605B |
| August 19, 2026 | 6.091B |
| August 18, 2026 | 5.585B |
| August 17, 2026 | 5.772B |
| August 14, 2026 | 5.820B |
| August 13, 2026 | 5.927B |
| August 12, 2026 | 5.950B |
| August 11, 2026 | 6.198B |
| August 10, 2026 | 6.272B |
| August 07, 2026 | 6.085B |
| August 06, 2026 | 5.311B |
| August 05, 2026 | 4.308B |
| August 04, 2026 | 4.209B |
| August 03, 2026 | 4.271B |
| July 31, 2026 | 4.087B |
| July 30, 2026 | 4.206B |
| July 29, 2026 | 4.065B |
| July 28, 2026 | 4.065B |
| July 27, 2026 | 4.076B |
| July 24, 2026 | 4.045B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| CareDx, Inc. | 3.103B |
| Natera, Inc. | 58.08B |
| Myriad Genetics, Inc. | 529.32M |
| BioRestorative Therapies, Inc. | -0.8314M |
| Exagen, Inc. | 200.73M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.637M |
| Revenue (Quarterly) | 263.71M |
| Total Expenses (Quarterly) | 264.35M |
| EPS Diluted (Quarterly) | -0.0022 |
| Gross Profit Margin (Quarterly) | 68.10% |
| Profit Margin (Quarterly) | -0.24% |
| Earnings Yield | 1.32% |
| Operating Earnings Yield | 1.92% |
| Normalized Earnings Yield | 1.571 |